scholarly journals Comparison of differing cytopathic effects in human airway epithelium of parainfluenza virus 5 (W3A), parainfluenza virus type 3, and respiratory syncytial virus

Virology ◽  
2011 ◽  
Vol 421 (1) ◽  
pp. 67-77 ◽  
Author(s):  
Liqun Zhang ◽  
Peter L. Collins ◽  
Robert A. Lamb ◽  
Raymond J. Pickles
Keyword(s):  
Respiratory Syncytial Virus ◽  
Virus Type ◽  
Airway Epithelium ◽  
Parainfluenza Virus ◽  
Cytopathic Effects ◽  
Human Airway ◽  
Human Airway Epithelium ◽  
Parainfluenza Virus 5 ◽  
Syncytial Virus ◽  
Type 3

scholarly journals A Prototype Recombinant Vaccine Against Respiratory Syncytial Virus and Parainfluenza Virus Type 3

1994 ◽  
Vol 12 (8) ◽  
pp. 813-818 ◽  
Author(s):  
Run-Pan Du ◽  
Gail E. D. Jackson ◽  
Philip R. Wyde ◽  
Wei-Yao Yan ◽  
Qijun Wang ◽  
...  
Keyword(s):  
Respiratory Syncytial Virus ◽  
Virus Type ◽  
Recombinant Vaccine ◽  
Parainfluenza Virus ◽  
Syncytial Virus ◽  
Type 3

scholarly journals Recombinant Bovine/Human Parainfluenza Virus Type 3 (B/HPIV3) Expressing the Respiratory Syncytial Virus (RSV) G and F Proteins Can Be Used To Achieve Simultaneous Mucosal Immunization against RSV and HPIV3

2001 ◽  
Vol 75 (10) ◽  
pp. 4594-4603 ◽  
Author(s):  
Alexander C. Schmidt ◽  
Josephine M. McAuliffe ◽  
Brian R. Murphy ◽  
Peter L. Collins
Keyword(s):  
Respiratory Syncytial Virus ◽  
Respiratory Tract ◽  
Host Range ◽  
Virus Type ◽  
Serum Antibody ◽  
Parainfluenza Virus ◽  
Range Restriction ◽  
Syncytial Virus ◽  
Human Parainfluenza Virus ◽  
Type 3

ABSTRACT Recombinant bovine/human parainfluenza virus type 3 (rB/HPIV3), a recombinant bovine PIV3 (rBPIV3) in which the F and HN genes were replaced with their HPIV3 counterparts, was used to express the major protective antigens of respiratory syncytial virus (RSV) in order to create a bivalent mucosal vaccine against RSV and HPIV3. The attenuation of rB/HPIV3 is provided by the host range restriction of the BPIV3 backbone in primates. RSV G and F open reading frames (ORFs) were placed under the control of PIV3 transcription signals and inserted individually into the rB/HPIV3 genome in the promoter-proximal position preceding the nucleocapsid protein gene. The recombinant PIV3 expressing the RSV G ORF (rB/HPIV3-G1) was not restricted in its replication in vitro, whereas the virus expressing the RSV F ORF (rB/HPIV3-F1) was eightfold restricted compared to its rB/HPIV3 parent. Both viruses replicated efficiently in the respiratory tract of hamsters, and each induced RSV serum antibody titers similar to those induced by RSV infection and anti-HPIV3 titers similar to those induced by HPIV3 infection. Immunization of hamsters with rB/HPIV3-G1, rB/HPIV3-F1, or a combination of both viruses resulted in a high level of resistance to challenge with RSV or HPIV3 28 days later. These results describe a vaccine strategy that obviates the technical challenges associated with a live attenuated RSV vaccine, providing, against the two leading viral agents of pediatric respiratory tract disease, a bivalent vaccine whose attenuation phenotype is based on the extensive host range sequence differences of BPIV3.

scholarly journals Virus isolations from patients in general practice, 1961–71

1974 ◽  
Vol 72 (2) ◽  
pp. 255-264 ◽  
Author(s):  
P. G. Higgins
Keyword(s):  
Respiratory Syncytial Virus ◽  
Virus Type ◽  
Mumps Virus ◽  
Influenza Viruses ◽  
Parainfluenza Virus ◽  
Parainfluenza Viruses ◽  
Syncytial Virus ◽  
Simplex Virus ◽  
Type 3

SUMMARYDuring the period 1961–71 of 1785 viruses isolated from patients in the general population 503 (28%) were rhinoviruses, 465 (26%) influenza viruses, 248 (14%) enteroviruses, 234 (13%) herpes simplex virus, 132 (7%) parainfluenza viruses, 129 (7%) adenoviruses and 49 (3%) respiratory syncytial virus. Also isolated were 18 strains of mumps virus, 7 coronaviruses and 295 streptococci of groups A, C or G.Fluctuations were observed in the frequency with which respiratory syncytial virus, parainfluenza virus type 2, and the adenoviruses were isolated over the 10-year period.Influenza viruses types A and B, parainfluenza viruses types 1 and 2, respiratory syncytial virus, adenoviruses types 3, 4, 6, 7 and 21, and many enteroviruses were all associated with outbreaks.Infections with influenza viruses A and B and parainfluenza viruses types 1 and 2 came during the winter, whereas those with parainfluenza virus type 3, enteroviruses, and rhinoviruses were more frequently seen in the summer and early autumn.

scholarly journals A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3

10.1038/71503 ◽  
2000 ◽  
Vol 6 (1) ◽  
pp. 35-40 ◽  
Author(s):  
Manoj K. Pastey ◽  
Tara L. Gower ◽  
Paul W. Spearman ◽  
James E. Crowe ◽  
Barney S. Graham
Keyword(s):  
Respiratory Syncytial Virus ◽  
Virus Type ◽  
Syncytium Formation ◽  
Parainfluenza Virus ◽  
Syncytial Virus ◽  
Type 3

scholarly journals Respiratory Syncytial Virus G and/or SH Glycoproteins Modify CC and CXC Chemokine mRNA Expression in the BALB/c Mouse

2000 ◽  
Vol 74 (13) ◽  
pp. 6227-6229 ◽  
Author(s):  
Ralph A. Tripp ◽  
Les Jones ◽  
Larry J. Anderson
Keyword(s):  
Respiratory Syncytial Virus ◽  
Mrna Expression ◽  
Virus Type ◽  
Parainfluenza Virus ◽  
Cxc Chemokine ◽  
Syncytial Virus ◽  
Type 3

ABSTRACT Chemokine mRNA expression by pulmonary leukocytes following infection of BALB/c mice with two strains of respiratory syncytial virus (RSV) and one strain of parainfluenza virus type 3 (PIV-3) was determined. The results suggest that RSV G and/or SH proteins inhibit early MIP-1α, MIP-1β, MIP-2, MCP-1, and IP-10 mRNA expression. TCA-3 mRNA expression was found to be increased during PIV-3 infection.

Sign in / Sign up

Export Citation Format

Share Document